R. Lazeron

发表

Slower progression of Parkinson’s disease in patients treated with ropinirole compared with L-dopa: REAL-PET – a randomised controlled 18F-dopa PET study

M. Filippi, A. Falini, C. Polman, 2002 .

Comparison of Medial Temporal Lobe Activation in Young and Elderly Subjects and Patients with Alzheimer's Disease.

M. Witter, S. Rombouts, P. Scheltens, 1998, NeuroImage.

Visual activation patterns in patients with optic neuritis

S. Rombouts, F. Barkhof, M. Sprenger, 1998, Neurology.

Multiple sclerosis

F. Barkhof, C. Polman, G. Giovannoni, 2003, Neurology.

Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging.

F Barkhof, W C Machielsen, S A Rombouts, 2000, AJNR. American journal of neuroradiology.

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study

C. Polman, B. Uitdehaag, G. Giovannoni, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis

F. Barkhof, C. Polman, B. Uitdehaag, 2004, Neurology.

Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.

C. Polman, B. Uitdehaag, M. Cuzner, 2002, Brain : a journal of neurology.

Axonal damage accumulates in the progressive phase of multiple sclerosis : A 3 – year follow – up study

R. Lazeron, M. Eikelenboom, C. Polman, 2009 .

Concurrent validity of the MS Functional Composite using MRI as a biological disease marker

F. Barkhof, C. Polman, V. de Groot, 2001, Neurology.